Craig-Hallum Initiates Coverage On Exagen with Buy Rating, Announces Price Target of $12
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Craig-Hallum analyst John Wilkin initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $12.
Craig-Hallum analyst John Wilkin initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $12.